Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data
Open Access
- 28 September 2018
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 28 (2) , 179-186
Abstract
Purpose: To quantify misclassification in glucocorticoid (GC) exposure defined using UK primary care prescription data.Methods: A cross‐sectional study including patients with rheumatoid arthritis prescribed oral GCs in the past 2 years. Glucocorticoid exposure based on electronic prescription records was compared with participant‐reported GC use captured using a paper diary. Prescription data (containing information about prescriptions issued but no dispensing information) was provided by the Clinical Practice Research Datalink. The following variables were defined: current use and dose of oral GCs and if (and when) participants had received a GC injection. For oral GCs, self‐reported use was taken to represent “true” exposure. A dataset representing a hypothetical population was generated to assess the impact of the misclassification found for current use.Results: A total of 67 of 78 study participants (86%) were correctly classified as currently on/off oral GCs; 32/38 (84.2%) participants reporting current GC use and 35/40 (87.5%) participants not reporting current use were correctly classified. Estimated values of current dose were imprecise (correlation coefficient 0.46). Concordance between reported and prescribed GC injections was poor (kappa statistic 0.14). Misclassification bias was demonstrated in the hypothetical population: For “true” relative risks of 1.5, 4, and 9, the “observed” relative risks were 1.33, 2.48, and 3.58, respectively.Conclusions: Misclassification of current use of oral GCs was low but sufficient to lead to significant bias. Researchers should take care to assess the likely impact of exposure misclassification on their analyses.Keywords
Funding Information
- Medical Research Council (G0902272)
- Arthritis Research UK (20380)
- National Institute for Health Research
This publication has 31 references indexed in Scilit:
- Validation and validity of diagnoses in the General Practice Research Database: a systematic reviewBritish Journal of Clinical Pharmacology, 2009
- Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three‐City (3C) StudyPharmacoepidemiology and Drug Safety, 2009
- Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic groupJournal of Clinical Epidemiology, 2008
- How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database?Arthritis Care & Research, 2008
- Corticosteroid-induced clinical adverse events: frequency, risk factors and patient?s opinionBritish Journal of Dermatology, 2007
- Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid usersPharmacoepidemiology and Drug Safety, 2006
- Proper interpretation of non-differential misclassification effects: expectations vs observationsInternational Journal of Epidemiology, 2005
- Pharmacy data in epidemiological studies: an easy to obtain and reliable toolPharmacoepidemiology and Drug Safety, 2002
- A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studiesJournal of Clinical Epidemiology, 1994
- DeprivationJournal of Social Policy, 1987